Arterial stiffness and endothelial function in the long-term period after a coronavirus disease 2019

QR Code

Arterial stiffness and endothelial function in the long-term period after a coronavirus disease 2019

Aim. To assess endothelial function and arterial stiffness over time in patients after hospitalization with coronavirus disease 2019 (COVID-19) and compare them with a control group.Material and methods. A total of 53 patients over 18 years of age were hospitalized for COVID-19 in June — August 2021...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. A. Bondar, O. P. Rotar, E. V. Moguchaya, M. А. Boyarinova, E. P. Kolesova, E. Yu. Vasilyeva, A. A. Mikhailova, T. L. Karonova, A. O. Konradi
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2024-06-01
Series:	Российский кардиологический журнал
Subjects:	covid-19 endothelium arterial stiffness vcam-1 von willebrand factor
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5803
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Factor fon Willebrand antigen in endothelium functional state assessment in patients with systemic lupus erythematosus
by: M E Zapryagaeva, et al.
Published: (2004-06-01)

The functional state of endothelium at chronic hepatitis C
by: I. A. Bulatova, et al.
Published: (2009-06-01)

Endothelial Dysfunction in Trauma: Pathogenesis, Clinical Significance, Diagnosis and Treatment
by: V. V. Matyukhin, et al.
Published: (2025-01-01)

Endothelial dysfunction in patients with various forms of congenital epidermolysis bullosa
by: V. I. Kornev, et al.
Published: (2022-11-01)

Probing rare von Willebrand disease–causing mutations in the D4 and C-domains of von Willebrand factor
by: Golzar Mobayen, et al.
Published: (2025-05-01)

Relationship between the D-dimer and von Willebrand factor levels and the development of gastrointestinal bleeding in patients with stable coronary artery disease: data from the registry of long-term antithrombotic therapy REGATTA-1
by: O. O. Shakhmatova, et al.
Published: (2021-11-01)

PROGNOSTIC SIGNIFICANCE OF ENDOTHELIAL DYSFUNCTION MARKERS IN ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2018-05-01)

Vascular-type heterogeneity is associated with differential gene expression profiles of endothelial cells under shear stress
by: Allaura A. Cox, et al.
Published: (2025-05-01)

Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01)

Relation of smoking and endothelial dysfunction markers in systemic hypertension
by: V. I. Podzolkov, et al.
Published: (2018-10-01)

Eric Adolf von Willebrand
by: N. A. Makatsariya
Published: (2021-11-01)

COMBINATION OF THE ULCERATIVE COLITIS AND VON WILLEBRAND DISEASE (A CASE REPORT)
by: I. A. Grishechkina, et al.
Published: (2017-08-01)

Maternal blood proteomics during relapse of early preeclampsia
by: M. G. Nikolaeva, et al.
Published: (2024-01-01)

A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
by: Benjamin Reardon, et al.
Published: (2025-07-01)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2021-03-01)

Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
by: A A Novikov, et al.
Published: (2004-08-01)

Clinical significance of ADAMTS-13/vWF axis in pregnant women at different trimesters of gestation
by: K. N. Grigoreva, et al.
Published: (2023-05-01)

Endothelial activation markers (VCAM-1, vWF) in patients with chronic hepatitis C and insulin resistance
by: T. V. Antonova, et al.
Published: (2014-09-01)

Pathomorphological diagnostics of chronic appendicitis (literature review)
by: N. N. Dremina, et al.
Published: (2017-09-01)

Clinical significance of assessing ADAMTS-13 and von Willebrand factor level in COVID-19 convalescent pregnant women
by: N. R. Gashimova, et al.
Published: (2023-03-01)

Vascular factor dynamics in therapy for microangiopathy with underlying type 1 diabetes mellitus
by: E. S. Krutikov, et al.
Published: (2020-12-01)

Comparison of endothelial function in patients with Stage I-II arterial hypertension and stable angina, receiving various bradycardic agents and perindopril
by: L. L. Kirichenko, et al.
Published: (1970-01-01)

Peculiarities of hemostasis changes under the influence of different regimens of antiplatelet therapy in patients with Q-wave myocardial infarction
by: S. M. Kyselov
Published: (2014-12-01)

Administration of plasma-derived coagulation factor VIII during the perioperative period of mastectomy for breast cancer with acquired von Willebrand syndrome
by: Ritsuko Sasaki, et al.
Published: (2018-09-01)

Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome—insights from a UK center
by: Giulia Simini, et al.
Published: (2025-07-01)

Bleeding due to a Broken Heart Valve: Heyde’s Syndrome Secondary to Severe Mitral Regurgitation
by: Bibek Saha, et al.
Published: (2025-01-01)

Normal Haemostasis, Inherited Bleeding Disorders and Surgery: What Does the Anaesthesiologist Need to Know?
by: Mihai Ștefan, et al.
Published: (2025-06-01)

Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellitus
by: A. V. Zhito, et al.
Published: (2020-01-01)

THE INVOLVEMENT OF ENDOTHELIAL DYSFUNCTION MARKERS IN THE PATHOGENESIS OF CHRONIC GLOMERULONEPHRITIS
by: T.V. Margieva, et al.
Published: (2006-03-01)

Pathogenetic and prognostic significance of inflammation and altered ADAMTS-13/vWF axis in patients with severe COVID-19
by: V. O. Bitsadze, et al.
Published: (2022-07-01)

Advances in Research on the Release of von Willebrand Factor from Endothelial Cells through the Membrane Attack Complex C5b-9 in Sepsis
by: Liu Y, et al.
Published: (2025-05-01)

ADAM and ADAMTS Proteases in Hepatic Disorders
by: Dirk Schmidt-Arras, et al.
Published: (2019-02-01)

Prevalence of heavy menstrual bleeding, iron deficiency, iron deficiency anemia, and treatment in women with von Willebrand disease—a cohort study
by: Linda Myrin–Westesson, et al.
Published: (2025-05-01)

EFFICACY AND SAFETY OF FIXED COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE FOR MANAGEMENT OF VASCULAR DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION
by: L. A. Haisheva
Published: (2016-01-01)

COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022-01-01)

Multidisciplinary approach to the diagnosis of disorders of coagulation system in childrenwith various pathologies
by: O. B. Gordeeva, et al.
Published: (2023-01-01)

Physical activity, vasomotor endothelial function, and arterial stiffness
by: S. M. Noskov, et al.
Published: (2012-12-01)

Hemodynamic activation of von Willebrand factor in children with congenital heart diseases
by: K. A. Tokmakova, et al.
Published: (2024-11-01)

SECONDARY PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC DISEASES OF CONNECTIVE TISSUE
by: N. A. Shostak, et al.
Published: (2016-01-01)

INVESTIGATION OF RISTOCETIN-INDUCED PLATELET AGGREGATION, PARAMETERS OF VON WILLEBRAND FACTOR AND THE COAGULATION FACTOR VIII AT ESSENTIAL ARTERIAL HYPERTENSION IN CHILDREN
by: M. V. Gomellya
Published: (2014-02-01)